Active Ingredient(s): Ursodeoxycholic Acid, Ursodiol
FDA Approved: * December 31, 1987
Pharm Company: * WATSON PHARMS
Category: Gallstones

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Actigall Overview

Ursodeoxycholic acid (UDCA), also known as ursodiol is one of the secondary bile acids, which are metabolic byproducts of intestinal bacteria. Contents 1 Medical uses 2 Endogenous effects 3 Mechanism of action 4 Names 5 See also 6 References 7 External links Medical uses An incomplete list of the current uses is as follows: Reduction in gallstone formation, either in patients with gallstones unfit for cholecystectomy, or obese patients undergoing rapid weight loss to prevent gallsto...

Read more Actigall Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Actigall Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ursodeoxycholic Acid, Ursodiol
  • Capsule: 150mg, 300mg
  • Tablet: 250mg, 500mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Actigall: (2 results)

Sorted by National Drug Code
  • 0023-6145 Actigall 300 mg Oral Capsule by Allergan, Inc.
  • 52544-930 Actigall 300 mg Oral Capsule by Watson Pharma, Inc.

Other drugs which contain Ursodeoxycholic Acid, Ursodiol or a similar ingredient: (2 results)

Related Actigall Topics:

Actigall for gallstones
Can Actigall be taken for gallstone treatment?...

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 22 November 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA